Prognostic value evaluation of HLA-DRB1* 07: 01,* 10,* 12,* 13: 01 alleles for alloimmunization in transfusion-dependent thalassemia

F Mezginejad, GRA Sarab, K Atarodi, A Oodi… - … and Apheresis Science, 2021 - Elsevier
Background Transfusion is a lifesaving treatment for lots of patients. However, in chronic
blood recipients such as thalassemia patients, there are high concerns about alloantibody …
被引用次数：3 相关文章

Prognostic Value Evaluation of HLA-DRB1* 07: 01,* 10,* 12,* 13: 01 Alleles for Alloimmunization in Transfusion-Dependent Thalassemia

F Mezginejad, GRA Sarab, K Atarodi… - … : official journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Transfusion is a lifesaving treatment for lots of patients. However, in chronic
blood recipients such as thalassemia patients, there are high concerns about alloantibody …

Prognostic Value Evaluation of HLA-DRB1* 07: 01,* 10,* 12,* 13: 01 Alleles for Alloimmunization in Transfusion-Dependent Thalassemia.

F Mezginejad, AS GR, K Atarodi, A Oodi… - … : Official Journal of the …, 2021 - europepmc.org
Background Transfusion is a lifesaving treatment for lots of patients. However, in chronic
blood recipients such as thalassemia patients, there are high concerns about alloantibody …

Prognostic Value Evaluation of HLA-DRB1* 07: 01,* 10,* 12,* 13: 01 Alleles for Alloimmunization in Transfusion-Dependent Thalassemia

F Mezginejad, GRA Sarab, K Atarodi, A Oodi… - … and Apheresis Science, 2021 - trasci.com
Background Transfusion is a lifesaving treatment for lots of patients. However, in chronic
blood recipients such as thalassemia patients, there are high concerns about alloantibody …